Learn More Learn more “Greater pathogen detection for better decisions” Clinical Diagnostics Biologics Genomic Service What’s NewTransgene chooses PathoQuest innovative NGS-based safety release test for TG4050 phase I clinical trial targeting patients with head-neck and ovarian cancers and for Invir.IO™ platform for recombinant viral vector manufacturing.20 February 2020PathoQuest to attend CAR-TCR Europe Summit – 24 to 27 February in London, UK14 February 2020PathoQuest’s Paris-based Facility Obtains GLP Certificate for the Company’s Biologics Genomic Quality Control Testing Service23 January 2020Save this Date – PathoQuest 3rd Annual Workshop: June 11, 2020 – Paris, France (Pre-Register Now)5 December 2019
